1. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival
    Ankur Pandey et al, 2018, Radiology CrossRef
  2. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography
    S.B. Paul et al, 2017, Diagnostic and Interventional Imaging CrossRef
  3. To what extent the DW-MRI and ADC value can be used in assessment of hepatic focal lesions in cirrhotic patients
    Moustafa Abdel Kader et al, 2017, The Egyptian Journal of Radiology and Nuclear Medicine CrossRef
  4. The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers
    Johannes Ludwig et al, 2015, Diagnostics CrossRef
  5. Subtraction MRI versus diffusion weighted imaging: Which is more accurate in assessment of hepatocellular carcinoma after Trans Arterial Chemoembolization (TACE)?
    Noha Abd ElShafy ElSaid et al, 2016, The Egyptian Journal of Radiology and Nuclear Medicine CrossRef
  6. Diagnostic value of apparent diffusion coefficient (ADC) in evaluating hepatocellular carcinomas post trans-catheter arterial chemoembolization and radiofrequency ablation
    Hazim I. Tantawy et al, 2016, The Egyptian Journal of Radiology and Nuclear Medicine CrossRef
  7. Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis
    Zhao Liu et al, 2020, Cancer Imaging CrossRef

  8. Pretreatment Apparent Diffusion Coefficient as a Predictor of Response to Transcatheter Arterial Chemoembolization Immediately Combined with Radiofrequency Ablation for Treatment of Solitary Large Hepatocellular Carcinoma


    Jing Tang et al, 2020, Cancer Management and Research CrossRef
  9. Role of diffusion-weighted MRI in differentiating between benign and malignant bone lesions: a prospective study
    T.M.M. Mansour et al, 2021, Clinical Radiology CrossRef
  10. Prognostication and response assessment in liver and pancreatic tumors: The new imaging
    Riccardo De Robertis et al, 2015, World Journal of Gastroenterology CrossRef
  11. Noninvasive magnetic resonance/photoacoustic imaging for photothermal therapy response monitoring
    Jing Ye et al, 2018, Nanoscale CrossRef
  12. Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional Treatment
    Zheng Yuan et al, 2016, Journal of Vascular and Interventional Radiology CrossRef
  13. Diffusion-weighted imaging compared to dynamic MRI in early response assessment of locoregional therapy (by trans-arterial chemoembolization & microwave ablation) of hepatocellular carcinoma
    Aya Ahmed Elboghdady et al, 2023, Egyptian Journal of Radiology and Nuclear Medicine CrossRef
  14. Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation
    Tim A. Labeur et al, 2019, Abdominal Radiology CrossRef
  15. Does diffusion‐weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd‐EOB‐DTPA with and without DWI
    Juliane Schelhorn et al, 2015, Journal of Magnetic Resonance Imaging CrossRef
  16. MRI assessment of hepatocellular carcinoma after locoregional therapy
    Rasha S. Hussein et al, 2019, Insights into Imaging CrossRef